Cumberland Pharmaceuticals (CPIX) Inventory Average (2011 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Inventory Average came in at $2.7 million in Q2 2026, down 25.1% year-over-year from $3.7 million in Q2 2025, and little changed quarter-over-quarter from $2.7 million in Q1 2026.
Analysis
Cumberland Pharmaceuticals (CPIX) Inventory Average (2011 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Inventory Average across 16 years of filings, most recently posting $2.7 million for Q2 2026.
- In Q2 2026, Inventory Average fell 25.1% year-over-year to $2.7 million; the TTM figure through Jun 2026 stood at $2.7 million (down 25.1% YoY), while the FY2025 annual figure was $2.0 million, down 53.19% from the prior year.
- Inventory Average came in at $2.7 million for Q2 2026 at Cumberland Pharmaceuticals, roughly flat from $2.7 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $10.6 million in Q2 2023 to a low of $1.5 million in Q4 2025.
- Average Inventory Average over 5 years is $6.2 million, with a median of $4.4 million recorded in 2024.
- Year-over-year, Inventory Average gained 9.73% in 2022 and plunged 65.16% in 2025.
- Over 5 years, Inventory Average stood at $10.3 million in 2022, then sank by 35.26% to $6.6 million in 2023, then slumped by 35.92% to $4.3 million in 2024, then sank by 65.16% to $1.5 million in 2025, then surged by 84.97% to $2.7 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $2.7 million in Q2 2026, $2.7 million in Q1 2026, and $1.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.38 Bn | 624.62 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 443.13 Bn | 436.56 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 365.40 Bn | 358.26 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 266.79 Bn | 259.10 Bn | 11.24 Bn | 6.25 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 10.31 Bn |
| 6 | Sanofi | 52.39 Bn | 45.00 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.92 Bn | 43.92 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 114.08 Mn |
| 9 | United Therapeutics | 21.55 Bn | 18.88 Bn | 683.80 Mn | 186.05 Mn |
| 10 | Cumberland Pharmaceuticals | 95.51 Mn | 91.65 Mn | - | 2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.74 Mn |
| Mar 31, 2026 | 2.74 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 3.66 Mn |
| Mar 31, 2025 | 4.05 Mn |
| Dec 31, 2024 | 4.25 Mn |
| Sep 30, 2024 | 4.41 Mn |
| Jun 30, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.47 Mn |
| Dec 31, 2023 | 6.64 Mn |
| Sep 30, 2023 | 9.80 Mn |
| Jun 30, 2023 | 10.55 Mn |
| Mar 31, 2023 | 10.02 Mn |
| Dec 31, 2022 | 10.26 Mn |
| Sep 30, 2022 | 10.03 Mn |
| Jun 30, 2022 | 9.65 Mn |
| Mar 31, 2022 | 9.15 Mn |
| Dec 31, 2021 | 9.35 Mn |
| Sep 30, 2021 | 10.18 Mn |